“…Our work and others’ point to a role for placental IL-17 and upstream IL-6 mechanisms in PNI programming. Placental diseases ranging from preeclampsia ( Lu et al, 2020 ; Eghbal-Fard et al, 2019 ; Molvarec et al, 2015 ; Pinheiro et al, 2013 ; Sowmya et al, 2015 ; Cornelius et al, 2016 ; Lockwood et al, 2008 ; Radulescu et al, 2016 ) to infection-associated spontaneous preterm birth ( Bhati et al, 2023 ), placental insufficiency ( Darmochwal-Kolarz et al, 2017 ), chorioamnionitis ( Lawrence et al, 2018 ), and chronic stress ( Bronson et al, 2014 ; Diz-Chaves et al, 2012 ; Gumusoglu et al, 2017 ; Mouihate et al, 2016 ; Veru et al, 2015 ) feature increased maternal-placental IL-17 and -6 and have a pathoetiology that is dependent on these cytokines ( Eghbal-Fard et al, 2019 ). IL-17 promotes pathologic placental trophoblast migration, viability, and invasion via PPAR-γ/RXR-α/Wnt signaling ( Zhang et al, 2022a ).…”